Jared Whitlock

Reporter

Email: jwhitlock@sdbj.com
Phone: 858-634-4636 Extension: 3130

Recent Stories

MabVax Sells Assets to German Company

BIOTECH: BioNTech Plans to Establish a Local Research Facility

The recent acquisition of San Diego’s MabVax has been a long time coming. MabVax sold its cancer drug assets and its lab equipment to German company BioNTech, it was announced earlier this month.

Trovagene and Nektar Strike Cancer Research Collaboration

San Diego’s Trovagene will partner with Nektar Therapeutics to explore combining their two drug candidates to treat metastatic colon cancer.

Locana Pulls in $55M to Repurpose CRISPR for RNA Therapies

Locana, a San Diego biotech that repurposed the gene-editing system CRISPR, has raised a $55 million series A round.

Reneo Pharmaceuticals Raises $50M Series A Round

San Diego’s Reneo Pharmaceuticals raised a $50 million Series A round to tackle metabolism and energy disorders.

Office Bridges Gap Between Discovery, Therapeutics

HEALTH: Arm of Moores Cancer Center Holds Annual Symposium

A department at UC San Diego Health’s Moores Cancer Center is known for putting on a symposium to translate groundbreaking oncology discoveries into therapeutics.

Tease photo

Chinese Pharma Co. Expands Its CRO Role in San Diego

PHARMA: Acquisitions Part of CRO Consolidation Trend Locally, Nationwide

WuXi AppTec is making moves in San Diego. The Chinese pharmaceutical company earlier this month bought San Diego-based Pharmapace.

Deploying AI at Hospitals Is Delicate Operation

HEALTH: Hospitals Grapple With Use, Costs and Concerns

Rady Children’s Hospital holds a world record for fastest genomic diagnosis. Instrumental in the feat: artificial intelligence.

Tease photo

AmpliPhi Biosciences Merges With Marina Del Rey Company

M&A: Co. Will Operate as Armata Pharmaceuticals

Two companies, new name. San Diego-based AmpliPhi Biosciences and Marina del Rey’s C3J Therapeutics have merged, operating as Armata Pharmaceuticals, focused on antibiotic-resistant infections.

Ra Medical Sues Strata Skin Sciences

Carlsbad’s Ra Medical Systems on May 16 sued Strata Skin Sciences and its board chair. The lawsuit alleges a campaign of false and misleading statements to financial partners before, during and after Ra Medical’s initial public offering.

Halozyme Reports Revenue Of $56.9 Million for First Quarter

BIOTECH: Co. Gets Licensing Fee From Argenx

San Diego-based Halozyme reported higher revenue and net income in first quarter results, thanks to the company’s platform technology. Looking forward, the company is heading for an inflection point.

Tease photo

More stories >>